loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Linagliptin

    Menu

    Linagliptin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,854Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 206073 / DOSAGE - TABLET;ORAL - 25MG;5MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EMPAGLIFLOZIN(UNII: HDC1R2M35U)
    (EMPAGLIFLOZIN - UNII:HDC1R2M35U)     		EMPAGLIFLOZIN10mg
    LINAGLIPTIN(UNII: 3X29ZEJ4R2)
    (LINAGLIPTIN - UNII:3X29ZEJ4R2)     		LINAGLIPTIN5mg